Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

234.17
-2.5500-1.08%
Volume:1K
Turnover:325.22K
Market Cap:469.86M
PE:- -
High:237.15
Open:237.15
Low:234.17
Close:236.72
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.81
T/O Rate:0.07%
Dividend:0.95
Dividend Rate:0.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Revolution Medicines Director Lorence H. Kim Disposes of Common Shares Worth $11.21 Million

Reuters
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 03

Political and General News Events from September 2

Reuters
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 02

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live
·
Sep 01

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Reuters
·
Sep 01

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01